Biotrial and CAP RESEARCH Forge Strategic Partnership to Expand Clinical Trial Access in the Indian Ocean and Eastern Africa

Biotrial is proud to announce that we are entering exclusive negotiations with CAP RESEARCH to establish a strategic partnership aimed at expanding access to diverse patient populations in the Indian Ocean and Eastern Africa. This collaboration seeks to combine Biotrial’s global expertise with CAP RESEARCH’s regional strength, enhancing clinical trial capabilities and accelerating drug development for sponsors worldwide.

Expanding Access to Diverse Patient Populations

The Indian Ocean and Eastern Africa regions are home to diverse populations that have historically been underrepresented in clinical research. By partnering with CAP RESEARCH, Biotrial aims to bridge this gap, ensuring that clinical trials are more inclusive and reflective of global demographics. This initiative aligns with our commitment to advancing health equity and improving the generalizability of clinical trial results.

Combining Global Expertise with Regional Strength

Biotrial brings over 35 years of experience as a full-service Contract Research Organization (CRO), offering comprehensive solutions in preclinical and clinical drug development. Our global presence includes facilities in Europe and North America, with a track record of conducting hundreds of studies annually.

CAP RESEARCH, with its deep roots in the Indian Ocean and Eastern Africa, offers unparalleled regional insights and access to local healthcare networks. Their expertise in patient recruitment and site management complements Biotrial’s capabilities, creating a synergistic partnership poised to deliver high-quality clinical trials in these regions.

Enhancing Clinical Trial Capabilities

This strategic alliance will focus on:

• Infrastructure Development: Establishing and enhancing clinical trial sites equipped with state-of-the-art facilities.

• Training and Capacity Building: Providing comprehensive training programs for local investigators and clinical staff to ensure adherence to international standards.

• Regulatory Navigation: Leveraging combined expertise to efficiently navigate regional regulatory landscapes, expediting trial initiation and execution.
  

Accelerating Drug Development for Sponsors

By expanding into the Indian Ocean and Eastern Africa, Biotrial and CAP RESEARCH aim to offer sponsors access to new patient populations, facilitating faster recruitment and more diverse data collection. This expansion is expected to enhance the robustness of clinical trial outcomes and support the development of therapies that are effective across varied populations.

Looking Ahead

As Biotrial and CAP RESEARCH move forward with this partnership, we remain committed to our mission of supporting innovative companies throughout their drug development process. This collaboration represents a significant step toward more inclusive and efficient clinical research, ultimately contributing to the delivery of effective cures to patients worldwide.

About Biotrial

Founded in 1989, Biotrial is a leading CRO specializing in drug development, conducting preclinical and clinical studies for biotech and pharmaceutical companies. With a global presence and a comprehensive range of services, Biotrial is dedicated to expediting the delivery of effective therapies to patients

About CAP RESEARCH

CAP RESEARCH is a prominent research organization based in the Indian Ocean and Eastern Africa, specializing in clinical trial management and patient recruitment. Their extensive regional experience and network make them an invaluable partner in conducting high-quality clinical research in these areas.